{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:46:27Z","timestamp":1787510787933,"version":"build-2736575974"},"reference-count":70,"publisher":"CSIRO Publishing","issue":"6","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":2475,"URL":"https:\/\/doi.org\/10.1071\/journalslicense"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,29]]},"abstract":"<jats:p>Pre-exposure prophylaxis (PrEP) is a well-established biomedical HIV prevention strategy and recommended to reduce HIV risk during peri-conception, pregnancy and breastfeeding. Efforts are needed to translate global recommendations into national guidelines and implementation strategies. This article presents the current status of policy guidance for the use of PrEP during peri-conception, pregnancy and breastfeeding, with a particular focus on high prevalence countries, including those in sub-Saharan Africa. PrEP clinical guidelines released by ministries of health or other national-level health bodies, with a particular focus on recommendations for PrEP use during peri-conception, pregnancy and breastfeeding, were reviewed and summarised. Among countries with PrEP guidelines and\/or policy, pregnancy is recognised as a period with increased HIV vulnerability, and some recommend PrEP use specifically during pregnancy. Only one country notes that PrEP is contraindicated during pregnancy, recognising a gap in complete safety data from women using PrEP throughout pregnancy. PrEP is not contraindicated as a peri-conception HIV prevention strategy in any country, but only three countries have specific guidance for peri-conception HIV prevention. Multiple barriers to the implementation of PrEP during pregnancy and breastfeeding are discussed, including barriers at the policy, health systems, social and personal levels. Although pregnancy is a period of heightened risk and fertility rates are high in many settings with high HIV burden, few PrEP policies have included guidance for PrEP use specific to peri-conception, pregnancy and breastfeeding periods. This gap can be overcome by the development or adoption of national clinical guidelines and implementation strategies from exemplary countries.<\/jats:p>","DOI":"10.1071\/sh18067","type":"journal-article","created":{"date-parts":[[2018,11,18]],"date-time":"2018-11-18T17:51:33Z","timestamp":1542563493000},"page":"501-512","source":"Crossref","is-referenced-by-count":32,"title":["Global and national guidance for the use of pre-exposure prophylaxis during peri-conception, pregnancy and breastfeeding"],"prefix":"10.1071","volume":"15","author":[{"given":"Natasha","family":"Davies","sequence":"first","affiliation":[{"name":"AWits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, 22 Esselen Street, Johannesburg, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6039-0352","authenticated-orcid":true,"given":"Renee","family":"Heffron","sequence":"additional","affiliation":[{"name":"BDepartments of Global Health and Epidemiology, University of Washington, 325 Ninth Avenue Box 359927, Seattle, WA 98104, USA."},{"name":"CCorresponding author. Email: rheffron@uw.edu"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"67","published-online":{"date-parts":[[2018,11,19]]},"reference":[{"issue":"5","key":"2025102617152384100_R1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"issue":"27","key":"2025102617152384100_R2","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"2025102617152384100_R3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.","volume":"367","author":"Thigpen","year":"2012","journal-title":"N Engl J Med"},{"key":"2025102617152384100_R4"},{"issue":"Suppl 2","key":"2025102617152384100_R5","doi-asserted-by":"publisher","first-page":"S145","DOI":"10.1097\/QAI.0000000000001063","article-title":"Cost-effectiveness of pre-exposure HIV prophylaxis during pregnancy and breastfeeding in Sub-Saharan Africa.","volume":"72","author":"Price","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025102617152384100_R6"},{"issue":"8","key":"2025102617152384100_R7","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.1016\/S2352-3018(16)30087-X","article-title":"Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980\u20132015: the Global Burden of Disease Study 2015.","volume":"3","author":"Global Burden of Disease Collaborators 2015.","year":"2016","journal-title":"Lancet HIV"},{"key":"2025102617152384100_R8"},{"key":"2025102617152384100_R9"},{"key":"2025102617152384100_R10"},{"issue":"15","key":"2025102617152384100_R11","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1097\/QAD.0b013e32834a9338","article-title":"Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples.","volume":"25","author":"Mugo","year":"2011","journal-title":"AIDS"},{"issue":"1","key":"2025102617152384100_R12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/infdis\/jiy113","article-title":"Increased risk of HIV acquisition among women throughout pregnancy and during the postpartum period: a prospective per-coital-act analysis among women with HIV-infected partners.","volume":"218","author":"Thomson","year":"2018","journal-title":"J Infect Dis"},{"issue":"2","key":"2025102617152384100_R13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001608","article-title":"Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis.","volume":"11","author":"Drake","year":"2014","journal-title":"PLoS Med"},{"issue":"6","key":"2025102617152384100_R14","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s10461-017-1777-7","article-title":"Consensus statement: supporting safer conception and pregnancy for men and women living with and affected by HIV.","volume":"22","author":"Matthews","year":"2018","journal-title":"AIDS Behav"},{"issue":"Suppl 1","key":"2025102617152384100_R15","doi-asserted-by":"publisher","first-page":"21309","DOI":"10.7448\/IAS.20.2.21309","article-title":"Delivering safer conception services to HIV serodiscordant couples in Kenya: perspectives from healthcare providers and HIV serodiscordant couples.","volume":"20","author":"Ngure","year":"2017","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"2025102617152384100_R16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1055\/s-0034-1395274","article-title":"Access to infertility care in the developing world: the family promotion gap.","volume":"33","author":"Asemota","year":"2015","journal-title":"Semin Reprod Med"},{"issue":"3","key":"2025102617152384100_R17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11904-016-0312-1","article-title":"PrEP as peri-conception HIV prevention for women and men.","volume":"13","author":"Heffron","year":"2016","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"6","key":"2025102617152384100_R18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/cid\/ciw850","article-title":"A risk assessment tool for identifying pregnant and postpartum women who may benefit from preexposure prophylaxis.","volume":"64","author":"Pintye","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2025102617152384100_R19"},{"issue":"1","key":"2025102617152384100_R20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2471\/BLT.17.200139","article-title":"Involving both parents in HIV prevention during pregnancy and breastfeeding.","volume":"96","author":"Chi","year":"2018","journal-title":"Bull World Health Organ"},{"issue":"2","key":"2025102617152384100_R21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4102\/sajhivmed.v12i2.196","article-title":"Guideline on safer conception in fertile HIV-infected individuals and couples.","volume":"12","author":"Bekker","year":"2011","journal-title":"SAJHIVMed."},{"key":"2025102617152384100_R22"},{"issue":"1","key":"2025102617152384100_R23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jogc.2017.06.033","article-title":"No. 354-Canadian HIV pregnancy planning guidelines.","volume":"40","author":"Loutfy","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"key":"2025102617152384100_R24"},{"issue":"3","key":"2025102617152384100_R25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S2055-6640(20)30338-1","article-title":"Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines.","volume":"3","author":"Wright","year":"2017","journal-title":"J Virus Erad"},{"key":"2025102617152384100_R26"},{"issue":"1","key":"2025102617152384100_R27","doi-asserted-by":"publisher","first-page":"a915","DOI":"10.4102\/sajhivmed.v19i1.915","article-title":"Guidelines to support HIV-infected individuals and couples to achieve pregnancy safely: update 2018.","volume":"19","author":"Davies","year":"2018","journal-title":"South Afr J HIV Med"},{"issue":"4","key":"2025102617152384100_R28","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1001\/jama.2014.8735","article-title":"Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial.","volume":"312","author":"Mugo","year":"2014","journal-title":"JAMA"},{"key":"2025102617152384100_R29","unstructured":"World Health Organization. WHO technical brief: preventing HIV in pregnancy and breastfeeding in the context of PrEP. Geneva, Switzerland: WHO; 2017. Available online at: http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/255866\/WHO-HIV-2017.09-eng.pdf;jsessionid=5B9D5C27A336E706DEAB4CD42266E62B?sequence=1 [verified 31 March 2018]."},{"key":"2025102617152384100_R30"},{"key":"2025102617152384100_R31"},{"key":"2025102617152384100_R32"},{"key":"2025102617152384100_R33"},{"key":"2025102617152384100_R34"},{"key":"2025102617152384100_R35"},{"key":"2025102617152384100_R36"},{"key":"2025102617152384100_R37"},{"key":"2025102617152384100_R38"},{"key":"2025102617152384100_R39"},{"key":"2025102617152384100_R40"},{"key":"2025102617152384100_R41","unstructured":"Gilead. Truvada check-list pour le m\u00e9decin prescripteur. Foster City, USA: Gilead; 2018. Available online at: http:\/\/ansm.sante.fr\/content\/download\/101989\/1293117\/version\/2\/file\/RTU_Truvada_Check-List-Prescripteurs_20-02-2017.pdf [verified 28 March 2018]."},{"issue":"3","key":"2025102617152384100_R42","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S2055-6640(20)30338-1","article-title":"Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines.","volume":"3","author":"Wright","year":"2017","journal-title":"J Virus Erad"},{"issue":"47","key":"2025102617152384100_R43","doi-asserted-by":"crossref","first-page":"E1448","DOI":"10.1503\/cmaj.170494","article-title":"Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis.","volume":"189","author":"Tan","year":"2017","journal-title":"CMAJ"},{"issue":"1","key":"2025102617152384100_R44","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jogc.2017.06.033","article-title":"No. 354-Canadian HIV Pregnancy Planning Guidelines.","volume":"40","author":"Loutfy","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"key":"2025102617152384100_R45","unstructured":"World Bank Group. World Bank open data. Washington, DC, USA: World Bank Group; 2018. Available online at: https:\/\/data.worldbank.org\/ [verified 15 March 2018]."},{"key":"2025102617152384100_R46","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). UNAIDS Country Data. Geneva, Switzerland: UNAIDS; 2018. Available online at: http:\/\/www.unaids.org\/en\/regionscountries\/countries [verified 31 March 2018]."},{"issue":"9","key":"2025102617152384100_R47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002133","article-title":"Tenofovir pre-exposure prophylaxis for pregnant and breastfeeding women at risk of HIV infection: the time is now.","volume":"13","author":"Mofenson","year":"2016","journal-title":"PLoS Med"},{"issue":"1","key":"2025102617152384100_R48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/COH.0000000000000224","article-title":"PrEP for Africa: what we have learnt and what is needed to move to program implementation.","volume":"11","author":"Mugo","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"2025102617152384100_R49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12688\/gatesopenres.12752.2","article-title":"Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa.","volume":"1","author":"Heffron","year":"2018","journal-title":"Gates Open Res"},{"issue":"3","key":"2025102617152384100_R50","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s40121-017-0159-9","article-title":"A review of HIV pre-exposure prophylaxis: the female perspective.","volume":"6","author":"Bailey","year":"2017","journal-title":"Infect Dis Ther"},{"issue":"3, Suppl 2","key":"2025102617152384100_R51","doi-asserted-by":"crossref","first-page":"19356","DOI":"10.7448\/IAS.17.3.19356","article-title":"Women and ARV-based HIV prevention \u2013 challenges and opportunities.","volume":"17","author":"Geary","year":"2014","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"2025102617152384100_R52","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s10461-016-1627-z","article-title":"Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: a systematic review of the literature.","volume":"21","author":"Koechlin","year":"2017","journal-title":"AIDS Behav"},{"issue":"1","key":"2025102617152384100_R53","first-page":"54","article-title":"Human resource challenges to integrating HIV pre-exposure prophylaxis (PrEP) into the public health system in Kenya: a qualitative study.","volume":"19","author":"Mack","year":"2015","journal-title":"Afr J Reprod Health"},{"issue":"1","key":"2025102617152384100_R54","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12978-017-0387-1","article-title":"Echoes of old HIV paradigms: reassessing the problem of engaging men in HIV testing and treatment through women\u2019s perspectives.","volume":"14","author":"Katirayi","year":"2017","journal-title":"Reprod Health"},{"issue":"Suppl 2","key":"2025102617152384100_R55","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1186\/1742-4755-12-S2-S8","article-title":"Adverse maternal and perinatal outcomes in adolescent pregnancies: the Global Network\u2019s Maternal Newborn Health Registry study.","volume":"12","author":"Althabe","year":"2015","journal-title":"Reprod Health"},{"key":"2025102617152384100_R56"},{"issue":"1","key":"2025102617152384100_R57","doi-asserted-by":"publisher","first-page":"18585","DOI":"10.7448\/IAS.17.1.18585","article-title":"Early adolescent pregnancy increases risk of incident HIV infection in the Eastern Cape, South Africa: a longitudinal study.","volume":"17","author":"Christofides","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"2025102617152384100_R58","unstructured":"World Health Organization. Adolescent pregnancy. Geneva, Switzerland: WHO; 2018 [updated January 2018]. Available online at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs364\/en\/ [verified 31 March 2018]."},{"issue":"6","key":"2025102617152384100_R59","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/03630242.2011.606355","article-title":"The prevalence and correlates of depressive symptoms among adolescent mothers: results from a 17-year longitudinal study.","volume":"51","author":"Gavin","year":"2011","journal-title":"Women Health"},{"key":"2025102617152384100_R60"},{"key":"2025102617152384100_R61"},{"issue":"1","key":"2025102617152384100_R62","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1186\/1471-2458-14-843","article-title":"South Africans with recent pregnancy rarely know partner\u2019s HIV serostatus: implications for serodiscordant couples interventions.","volume":"14","author":"Matthews","year":"2014","journal-title":"BMC Public Health"},{"issue":"9","key":"2025102617152384100_R63","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1600693","article-title":"Antiretroviral therapy for the prevention of HIV-1 transmission.","volume":"375","author":"Cohen","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"2025102617152384100_R64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone. 0016986","article-title":"Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial.","volume":"6","author":"Campbell","year":"2011","journal-title":"PLoS One"},{"key":"2025102617152384100_R65","doi-asserted-by":"publisher","first-page":"18832","DOI":"10.7448\/IAS.17.1.18832","article-title":"Challenges with couples, serodiscordance and HIV disclosure: healthcare provider perspectives on delivering safer conception services for HIV-affected couples, South Africa.","volume":"17","author":"Crankshaw","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"2025102617152384100_R66","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.srhc.2016.03.005","article-title":"Client and provider knowledge and views on safer conception for people living with HIV (PLHIV).","volume":"10","author":"Mindry","year":"2016","journal-title":"Sex Reprod Healthc"},{"issue":"1, Suppl 2","key":"2025102617152384100_R67","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1016\/j.amepre.2012.09.047","article-title":"Adherence to antiretroviral medications for HIV pre-exposure prophylaxis: lessons learned from trials and treatment studies.","volume":"44","author":"Koenig","year":"2013","journal-title":"Am J Prev Med"},{"issue":"3, Suppl 2","key":"2025102617152384100_R68","doi-asserted-by":"crossref","first-page":"19146","DOI":"10.7448\/IAS.17.3.19146","article-title":"Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.","volume":"17","author":"van der Straten","year":"2014","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"2025102617152384100_R69","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s10461-014-0950-5","article-title":"Male partner influence on women\u2019s HIV prevention trial participation and use of pre-exposure prophylaxis: the importance of \u201cunderstanding\u201d.","volume":"19","author":"Montgomery","year":"2015","journal-title":"AIDS Behav"},{"key":"2025102617152384100_R70","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2147\/IJWH.S8632","article-title":"Partner violence during pregnancy: prevalence, effects, screening, and management.","volume":"2","author":"Bailey","year":"2010","journal-title":"Int J Women\u2019s Health"}],"container-title":["Sexual Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/15\/6\/501\/1255621\/sh18067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/15\/6\/501\/1255621\/sh18067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:15:33Z","timestamp":1761513333000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/sh\/article\/15\/6\/501\/185040\/Global-and-national-guidance-for-the-use-of-pre"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,19]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11,29]]}},"URL":"https:\/\/doi.org\/10.1071\/sh18067","relation":{},"ISSN":["1448-5028","1449-8987"],"issn-type":[{"value":"1448-5028","type":"print"},{"value":"1449-8987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,19]]}}}